Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic testing in cardiomyopathies: do we need to redefine the UK national testing criteria?

Open heart - 21 Jan 2026

Madu Andrew Chisom, Dimarco Anthony David, Hardy-Wallace Amy, Ganapathy Archana, Savage Henry Oluwasefunmi, Dungu Jason N

Abstract excerpt

INTRODUCTION: Inherited cardiac conditions, including dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM), may have a monogenic cause identified through genetic testing (GT). Confirmation of pathogenic gene variants can have important implications for the patient and their relatives. The UK National Genomic Test Directory (NGTD) provides strict criteria on the indications for GT; however, the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathies
Share to Cardiomyopathy, Dilated

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cardiomyopathy, Hypertrophic

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Mutation

Share to Phenotype

Share to United Kingdom

Source

Open in PubMed Open full text

Identifiers

PMID: 41565355
DOI: 10.1136/openhrt-2025-003838
PMCID: PMC12829349

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic testing in cardiomyopathies: do we need to redefine the UK national testing criteria?PMID 41565355Read ↗

Integration of genetic testing into diagnostic pathways for cardiomyopathies: a clinical consensus statement by the ESC Council on Cardiovascular GenomicsSemantic proximity Read ↗

ESC EORP Cardiomyopathy Registry: Real-Life Practice of Genetic Counselling and Testing in Adult Cardiomyopathy PatientsSemantic proximity Read ↗

Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients.Semantic proximity Read ↗

Diagnostic validity and clinical utility of genetic testing for hypertrophic cardiomyopathy: a systematic review and meta-analysis.Semantic proximity Read ↗

Contemporary genetic testing in inherited cardiac disease: tools, ethical issues, and clinical applications.Semantic proximity Read ↗

Diagnostic yield of genetic testing in a multinational heterogeneous cohort of 2088 DCM patientsSemantic proximity Read ↗

The Rationale and Timing of Molecular Genetic Testing for Dilated Cardiomyopathy.Semantic proximity Read ↗

Cardiomyopathies and Genetic Testing in Heart Failure: Role in Defining Phenotype-Targeted Approaches and Management.Semantic proximity Read ↗

Genetic testing in cardiomyopathies: updates and future perspectives.Semantic proximity Read ↗

Challenges and Applications of Genetic Testing in Dilated Cardiomyopathy: Genotype, Phenotype and Clinical Implications.Semantic proximity Read ↗

Cardiac genetic test yields and genotype-phenotype correlations from large cohort investigated by medical examiner's office.Semantic proximity Read ↗

Results of comprehensive genetic testing in patients presenting to a multidisciplinary inherited heart disease clinic in India.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.